Geode Capital Management
PRCT icon

Geode Capital Management’s Procept Biorobotics PRCT Stock Holding History

Geode Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.3M Sell
1,333,776
-150,387
-10% -$3M ﹤0.01% 2003
2026
Q2 		$33.5M Buy
1,484,163
+120,663
+9% +$3.02M ﹤0.01% 1855
2026
Q1 		$34.1M Buy
1,363,500
+34,986
+3% +$986K ﹤0.01% 1710
2025
Q4 		$41.8M Buy
1,328,514
+21,309
+2% +$707K ﹤0.01% 1606
2025
Q3 		$46.7M Buy
1,307,205
+8,311
+0.6% +$379K ﹤0.01% 1508
2025
Q2 		$74.8M Buy
1,298,894
+115,229
+10% +$6.51M 0.01% 1202
2025
Q1 		$69M Buy
1,183,665
+19,628
+2% +$1.34M 0.01% 1186
2024
Q4 		$93.8M Buy
1,164,037
+57,449
+5% +$4.91M 0.01% 1041
2024
Q3 		$88.7M Buy
1,106,588
+84,244
+8% +$5.99M 0.01% 1073
2024
Q2 		$62.5M Buy
1,022,344
+61,003
+6% +$3.63M 0.01% 1203
2024
Q1 		$47.5M Buy
961,341
+29,850
+3% +$1.42M ﹤0.01% 1390
2023
Q4 		$39M Buy
931,491
+89,286
+11% +$3.04M ﹤0.01% 1498
2023
Q3 		$27.6M Buy
842,205
+129,014
+18% +$4.4M ﹤0.01% 1621
2023
Q2 		$25.2M Buy
713,191
+119,313
+20% +$3.95M ﹤0.01% 1698
2023
Q1 		$16.9M Buy
593,878
+32,645
+6% +$1.15M ﹤0.01% 1916
2022
Q4 		$23.3M Buy
561,233
+33,203
+6% +$1.43M ﹤0.01% 1668
2022
Q3 		$21.9M Buy
528,030
+217,362
+70% +$8.67M ﹤0.01% 1665
2022
Q2 		$10.2M Buy
310,668
+139,042
+81% +$5.06M ﹤0.01% 2240
2022
Q1 		$6M Buy
171,626
+11,446
+7% +$275K ﹤0.01% 2691
2021
Q4 		$4.01M Buy
160,180
+150,952
+1,636% +$5.58M ﹤0.01% 3014
2021
Q3 		$352K Buy
+9,228
New +$354K ﹤0.01% 4190

Other funds holding PRCT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Geode Capital Management's PRCT Position: Q3 2026 in Review

Geode Capital Management reduced its Procept Biorobotics (PRCT) stake by 10% in Q3 2026, selling an estimated $3M and leaving 1,333,776 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Geode Capital Management first reported a position in PRCT in Q3 2021 and has held it in 21 quarters since. The position peaked at $93.8M in Q4 2024. 171 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Geode Capital Management held 1,333,776 shares of Procept Biorobotics worth $24.3M as of Q3 2026.
  • Geode Capital Management sold 150,387 Procept Biorobotics shares in Q3 2026, an estimated $3M.
  • Procept Biorobotics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2003 holding.
  • Geode Capital Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Procept Biorobotics position peaked at $93.8M in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.